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A B S T R A C T
Paroxysmal kinesigenic dyskinesia (PKD) is presented as a short paroxysmal attack of focal or
generalized involuntary movement. Bilateral striopallidodentate calcinosis (BSPDC) is referred to as
Fahr’s disease and is characterized by the calciﬁcation of the basal ganglia, cerebellar nuclei and
thalamus. Most common presentation of BSPDC was a parkinsonism, and PKD has also been reported to
few of the cases with sporadic BSPDC. Here, we report the case of a 35-year-old-man with PKD for
19 years, and we describe the pathogenesis of PKD in the BSPDC.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Because Fahr had previously described a case report of a man
with hypoparathyroidism and calciﬁcation of the basal ganglia
(BG), all forms of bilateral calciﬁcations of the BG and other parts of
the brain are now associated with Fahr’s name.1,2 Because these
calciﬁcations tend to show a predilection for the dentate nuclei and
BG, the descriptive term ‘‘bilateral striopallidodentate calcinosis
(BSPDC)’’ has been suggested,3,4 in addition to being referred to as
Fahr’s disease.5 Common lesions of BSPDC of the BG generally
occur in the globus pallidus, dentate nucleus (DN) of cerebellum,
thalamus and centrum semiovale.1 Because calcium and other
mineral deposits are the major components accounting for its
radiological appearance, a computed tomography (CT) scan is
considered to be more sensitive than a magnetic resonance
imaging (MRI) scan to search for deposits of BSPDC.4 The most
commonmanifestations of BSPDC aremovement disorders such as
parkinsonism and other hyperkinetic movements, which are
followed by cognitive impairment, cerebellar ataxia and speech
disorder.1
Paroxysmal kinesigenic dyskinesia (PKD) consists of any
combination of dystonic postures, chorea, athetosis and ballism.
PKD is brief, usually lasting seconds up to 5 min, and is precipitated
by a sudden movement or by startles.6 Although the etiology of
most PKD case reports has been idiopathic, symptomatic or
secondary PKD has also been established.6 Speciﬁcally, PKD has* Corresponding author at: Department of Neurology, Inje University College of
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http://dx.doi.org/10.1016/j.seizure.2012.08.004been reported to occur with BSPDC without hypoparathyroidism.7
However, the pathophysiology of PKD is still unclear and its
relationship with epilepsy has remained unresolved.
Here, we report the case of a 35-year-old-man with PKD for
19 years. He has also been treated with carbamazepine, and his
symptoms have improved.
An assessment using brain imaging (CT) of this case and a
review of the related literature was performed to more clearly
deﬁne the effects of BSPDC in the pathogenesis of PKD.
2. Case report
A 35-year-old man presented with intermittent paroxysmal
episodic involuntary movements since the age of 16 years. He
reported a stiffening of his legs, inversion and dystonia of his feet,
ﬂexion of his right hands into a clawed position, and tightness in
his neck which are consistent with PKD. Dystonia was revealed on
both feet; in particular, it was more frequent and severe on the
right foot. The duration of the episode was 5–10 s. During an
episode, he was unable to stand, was poorly mobile, and would
sometimes fall down. However, no pain or loss of consciousness
occurred during the attacks. Large meals or prolonged rest did not
trigger the events, although most of the episodes occurred after
standing up suddenly from a seated position after a prolonged rest
state. The episodes were occurred approximately 20–30 times per
day. The patient denied experiencing any auras, rhythmic
twitching, tongue-biting, loss of bowel or bladder control, postictal
sleepiness, or headaches.
His birth, delivery, and development were unremarkable. He
had no other signiﬁcant medical history, and there was a lack of a
family history of neurological or psychiatric disorders. A general
physical and neurological examination produced normal results.vier Ltd. All rights reserved.
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Fig. 1. A brain CT revealed marked intracerebral calciﬁcation in the bilateral BG and DN of the cerebellum.
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mality. A CT scan revealed a bilateral calciﬁcation in the BG and DN
of the cerebellum (Fig. 1). Laboratory studies revealed normal
levels of calcium serum (9.1 mg/dL), inorganic phosphorus
(3.5 mg/dL), and parathyroid hormone (30.38 pg/ml). Serum free
T4 was slightly elevated (1.81 ng/dL); however, serum T3, T4, TSH,
free T4, thyroglobulin Ab, and microsomal Ab were within the
normal limits in a follow-up thyroid function exam. Moreover, the
serum ceruloplasmin and copper levels were normal. An anti-
nuclear antibody was negative. Other routine hematological
examinations (hemoglobin, total and differential count) and blood
biochemistry (glucose, creatine, liver function test, sodium,
potassium) were within the normal limits. Genetic test of PRRT2
mutation on the chromosome 16, which has been related with
infantile seizure and adolescent movement disorder PKD.8 Despite
of this very helpful suggestion, because he did not want to do any
more laboratory tests, we could not perform the gene study.
Furthermore, his involuntary movements had improved in
response to carbamazepine (100 mg/day).
3. Discussion
The diagnostic criteria of PKD include an identiﬁed kinesigenic
trigger for the attacks, a short attack duration (<5 min), no pain or
loss of consciousness during the attacks, a usual age of onset
between 1 and 20 years (if there is no family history of PKD), the
exclusion of other organic diseases, normal results of an interictal
neurological examination, and control of the attacks with a low-
dose of carbamazepine or phenytoin.9,10 The hyperkinetic move-
ments exhibited by our patient satisﬁed these criteria; however,
we suspected his attacks to be a BSPDC of symptomatic cases in
PKD because of the calciﬁcation of the BG andDN of the cerebellum
in a CT scan. BSPDC is the rare cause of secondary cases in PKD.
Although neuronal degeneration and gliosis surrounding the
calcium accumulation of the BG are major pathologies,5 the exact
reason why the BG is vulnerable to calcium deposits has not yet
been fully established. The major differential diagnosis of BSPDC is
hypoparathyroidism. Our patient’s serum laboratory results
indicated that his calcium and parathyroid hormone levels were
all normal.
Over the years, a substantial debate has occurred whether PKD
is an epileptic or a non-epileptic disorder.11 The epileptic origin is
clinically supported by the brief, paroxymal, stereotyped nature of
the attacks and the dramatic response to anticonvulsants.9 PKC has
been suggested to a peculiar form of reﬂex epilepsy.12 In addition,
PKC was co-occurred in families affected by the infantile
convulsions and choreoathetosis (ICCA) syndrome, and they wereassociated with PRRT2 mutations in the same gene on the
chromosome16.8 However, no typical ictal or interictal changes
in the EEG, the lack of a family or past medical history of epilepsy,
and the preservation of consciousness support the idea that PKD is
not an epileptic disorder.13 Thus, some studies suggest a
subcortical origin of the epileptogenic source in the BG.11,13
Other studies have considered PKD to be a BG disorder rather
than a form of epilepsy.14,15 Recently, a neurophysiological study
based on the dysfunction of the BG circuit suggests that an
impaired cortical and spinal inhibition is important for the
differentiation of PKD from epilepsy.16 In addition, a cerebral
perfusion SPECT abnormality of the bilateral caudate nuclei in PKD
supports the BG theory.15 However, the pathogenic association
between PKD and BSPDC has not been fully established. Based on
our current knowledge, damage to the BG or to the cerebellar loop
of the motor areas of the cortex leads to motor symptoms.17
Because of no family history of movement disorders and past
medical history of infantile seizure, he is able to be clinically and
radiologically diagnosed with idiopathic primary BSPDC despite of
unperforming genetic study of PRRT2 mutation. Therefore, we
suggest that a broad and massive bilateral calciﬁcation of the BG
and cerebellum may drive PKD in our patient.
To our knowledge, this is the second case of BSPDC who
presented with PKD, which strongly supports the BG theory.
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